Judith S. Pelton

Segretario Aziendale presso Phage Biotechnology Corp.

Commercial Services

Health Technology

Profilo

Judith Pelton is Corporate Secretary of Phage Biotechnology Corp.
and CardioVascular BioTherapeutics, Inc. She has been a Director of C.K.
Capital Corp.
since January, 1997.
Ms. Pelton worked for the Investment-Banking Department at Brookstreet Securities Corp.
from 1995 to 1996.
She was Vice President of Administration, Handling Regulatory and Administrative Functions for Montano Securities Corp.
from 1984 to 1994.
Ms. Pelton has over 25 years of experience in the investment and securities business.

Posizioni attive di Judith S. Pelton

Società	Posizione	Inizio
Phage Biotechnology Corp. Phage Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Phage Biotechnology Corp. manufactures protein pharmaceuticals including pegylated human growth hormone, pegylated G-CSF, pegylated interferon alpha, beta interferon, and single-chain antibodies. It also develops biopharmaceuticals whose patents expire. The company was founded in 1998 and is headquartered in Las Vegas, NV.	Segretario Aziendale	-

Tutte le posizioni attive di Judith S. Pelton

Precedenti posizioni note di Judith S. Pelton

Società	Posizione	Fine
Venturis Therapeutics, Inc. Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX.	Segretario Aziendale	-

Vedi nel dettaglio l'esperienza di Judith S. Pelton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Judith S. Pelton

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Venturis Therapeutics, Inc. Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX.	Commercial Services
Phage Biotechnology Corp. Phage Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Phage Biotechnology Corp. manufactures protein pharmaceuticals including pegylated human growth hormone, pegylated G-CSF, pegylated interferon alpha, beta interferon, and single-chain antibodies. It also develops biopharmaceuticals whose patents expire. The company was founded in 1998 and is headquartered in Las Vegas, NV.	Health Technology